Total Funding
86
61
Total FundingVenture - Series Unknown raised
Growth Score 86 in past quarter
-6 pts
Heat Score 61 in past quarter
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
43216
Mercury Bio is a biomolecular delivery platform that transforms and treats viral diseases, cancer, and inflammatory conditions.
- Bruce McCormick: CEOPast Role: BioLife Solutions, Senior Vice President
- Cassandra Perkins: Vice President of Corporate Strategy & Business DevelopmentPast Role: Syneos Health, Director of Value & Market Access
About the Company
Mercury Bio is a biomolecular delivery platform that transforms and treats viral diseases, cancer, and inflammatory conditions. Its platform delivers natural-like RNA molecules to specific cells and organs and destroys the virus's RNA, without affecting the human genes, blocking further replication and spread of the virus while enhancing the
production of essential hormones such as insulin.